Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Abionyx, Allogene, Amryt, Avacta, CASI, Cerecor, Halozyme, Hoth, Innovent, J&J, Juventas Cell Therapy, Moderna, Neurocrine, Novadip, Polarean, RFID, Ridgeback, Roche, Shenyang Tonglian, SOBI, Spectrum, Tarsus, VBI, Voyager.